Tranexamic Acid in Reducing Blood Loss in Patients With Pelvic Tumors Undergoing Hemipelvectomy Surgery
Status:
Recruiting
Trial end date:
2021-05-31
Target enrollment:
Participant gender:
Summary
This early phase I trial studies how well tranexamic acid works in reducing the loss of blood
in patients with pelvic tumors undergoing hemipelvectomy surgery. Tranexamic acid decreases
blood loss by stabilizing clots and preventing clot lysis in patients undergoing surgery.